GRFSGrifols, S.A.

$7.89

$7.0052 weeks$10.74

Price

$7.89-25%1Y

1M+4.5%1Y-25%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average

8/10

Value83

Quality76

Momentum36

Growth20

Strongest Value, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are one of the leading global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value.

In the company’s own words · 20-F filed Apr 17, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$5.04B

1Y Return-25%

5Y Return-47%

For the full year FY2024, revenue was €7.21B (+9.4% year on year) and net income €157M.